trending Market Intelligence /marketintelligence/en/news-insights/trending/vk863lk4ClHvq1_foKrfgg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Mass. regulator clears Curaleaf's acquisition of medical marijuana business

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Mass. regulator clears Curaleaf's acquisition of medical marijuana business

Curaleaf Holdings Inc. said its acquisition of a medical marijuana business in Massachusetts was cleared by the Massachusetts Cannabis Control Commission, a regulator in the state.

Curaleaf was required to seek the regulator's approval to buy Curaleaf Massachusetts Inc. which owns medical marijuana dispensaries in the state, according to the Boston Business Journal. The deal was unrelated to Curaleaf's other acquisitions announced earlier this year.